Sinclair
- Consolidated Income Statement
- Balance Sheet
- Statement of Changes in Shareholders' Equity
- Cash Flow Statements
- Notes to the Financial Statements
- 1. General information
- 2. Accounting Policies
- 3. Financial risk management
- 4. Segmental information
- 5. Exceptional operating items
- 6. Expenses by nature
- 7. Employees and Directors
- 8. Finance Income and costs
- 9. Taxation on loss on ordinary activities
- 10. Loss for the financial year
- 11. Loss per share
- 12. Goodwill
- 13. Intangible asssets
- 14. Property, plant and equipment
- 15. Investments
- 16. Deferred tax asset
- 17. Inventories
- 18. Trade and other receivables
- 19. Trade and other payables
- 20. Borrowings
- 21. Provisions
- 22. Financial instruments
- 23. Called-up share capital
- 24. Share premium
- 25. Options and warrants over shares of Sinclair Pharma plc
- 26. Share based payments
- 27. Other Reserves
- 28. Cash flows from operating activities
- 29. Operating lease commitments
- 30. Capital commitments
- 31. Related party transactions
- 32. Post balance sheet events
29 Operating lease commitmentsAt 30 June 2009 the Group has commitments in respect of non-cancellable operating leases as follows: |
||||||
|
2009 |
2008 |
|||||
|
Group |
Land & buildings £’000 |
Equipment £’000 |
Total £’000 |
Land & buildings £’000 |
Equipment £’000 |
Total £’000 |
|
Commitments under non-cancellable operating leases |
||||||
|
Within one year |
348 |
186 |
534 |
670 |
235 |
905 |
|
Between two and five years |
441 |
81 |
522 |
1,170 |
82 |
1,252 |
|
After 5 years |
– |
– |
– |
249 |
1 |
250 |
|
789 |
267 |
1,056 |
2,089 |
318 |
2,407 |
|
|
Company There were no operating lease commitments for the Company at 30 June 2009 (2008: nil) |
||||||